Clinical Trials in Haerbin, China
Locations / Haerbin, China
Delta Trials records 146 clinical trials conducted in Haerbin, China, making it a notable site of clinical research activity. These trials across 155 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 6 trials in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Haerbin has changed over time.
146
Total Trials
155
Conditions
6
Terminated since 2020
Browse by condition (155 total)
- Non-small cell lung cancer 9 trialsAll Non-small cell lung cancer trials
- Diabetes mellitus, type 2 5 trialsAll Diabetes mellitus, type 2 trials
- Acute ischemic stroke 5 trialsAll Acute ischemic stroke trials
- Advanced solid tumor 4 trialsAll Advanced solid tumor trials
- Breast neoplasms 3 trialsAll Breast neoplasms trials
- Chronic heart failure 3 trialsAll Chronic heart failure trials
- Hepatocellular carcinoma 2 trialsAll Hepatocellular carcinoma trials
- Solid tumors 2 trialsAll Solid tumors trials
- Small cell lung cancer 2 trialsAll Small cell lung cancer trials
- Her2-positive breast cancer 2 trialsAll Her2-positive breast cancer trials
- Solid tumor 2 trialsAll Solid tumor trials
- Diffuse large B-cell lymphoma 2 trialsAll Diffuse large B-cell lymphoma trials
- Familial alzheimer disease (fad) 2 trialsAll Familial alzheimer disease (fad) trials
- Atherosclerosis 2 trialsAll Atherosclerosis trials
- Type 2 diabetes 2 trialsAll Type 2 diabetes trials
- Breast cancer 2 trialsAll Breast cancer trials
- Advanced solid tumors 2 trialsAll Advanced solid tumors trials
- Renal cell carcinoma 2 trialsAll Renal cell carcinoma trials
- Rheumatoid arthritis 2 trialsAll Rheumatoid arthritis trials
- Atrial fibrillation 2 trialsAll Atrial fibrillation trials